Recon: Drugmakers ring in 2025 with new round of pricing hikes; FDA approved 50 new drugs, 11 biologics in 2024
ReconJason Scott
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)